QingSong Health Corporation (HKG:2661)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
5.93
+0.15 (2.60%)
Jul 31, 2026, 4:08 PM HKT

QingSong Health Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
1,2561,256945.01489.96393.61
Revenue Growth
0.80%32.90%92.87%24.48%-
Gross Profit
435.14435.14361.63391.48325.16
Operating Income
73.5273.5259.48142.7146.54
Net Income
-379.72-379.7210.473.65-2.06
Earnings Per Share
-4.58-4.580.100.60-0.03
EPS Growth
---82.75%--

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Cash & Investments
957.07957.07362.58321.64295.61
Total Debt
3.383.381,7541,6881,609
Net Cash (Debt)
953.7953.7-1,391-1,366-1,313
Net Cash Growth
-----
Net Cash Per Share
11.5111.51-13.78-6.75-16.40

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
82.0982.0983.797.8357.2
Capital Expenditures
-0.72-0.72-1.01-0.18-
Free Cash Flow
81.3781.3782.797.6557.2
Free Cash Flow Growth
-9.29%-1.71%981.75%-86.62%-

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22
Gross Margin
34.65%34.65%38.27%79.90%82.61%
Operating Margin
5.85%5.85%6.29%29.13%37.23%
Pretax Margin
-30.17%-30.17%0.78%21.34%1.61%
Profit Margin
-30.23%-30.23%1.10%15.03%-0.52%
FCF Margin
6.48%6.48%8.76%1.56%14.53%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
P/FCF Ratio
13.51156.23---
PS Ratio
0.8810.12---